Metabolic Risk Assessment in Prepubertal Children With Congenital Hypothyroidism

NCT07126353 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2025-08-17

No results posted yet for this study

Summary

We propose a multicenter prospective study to define the prevalence and severity score of metabolic syndrome in a prepubertal pediatric cohort with congenital hypothyroidism, compared to a healthy and normal-weight pediatric population. These data will help to define whether hypothyroidism can be considered a risk factor for the metabolic health of the pediatric population. The possible identification of an at-risk metabolic profile will provide useful information to optimize the diagnostic and monitoring pathway for affected children.

Conditions

  • Congenital Hypothyroidism
  • Metabolic Syndrome

Interventions

OTHER

prospective observational study (clinical, hormonal and auxological data)

We collect clinical, hormonal and auxological data and compare them between the two groups.

Sponsors & Collaborators

  • Federico II University

    collaborator OTHER
  • IRCCS Ospedale San Raffaele

    collaborator OTHER
  • Policlinico di Bari Giovanni XXIII

    collaborator UNKNOWN
  • Azienda Ospedaliero Universitaria Policlinico Modena

    collaborator OTHER
  • Azienda Ospedaliero-Universitaria di Parma

    collaborator OTHER
  • Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna

    collaborator OTHER
  • Azienda Ospedaliera Sant'Anna

    collaborator OTHER
  • University Hospital Perugia

    collaborator UNKNOWN
  • University of L'Aquila

    collaborator OTHER
  • Clinica Pediatrica Università di Novara

    collaborator UNKNOWN
  • Santobono-Pausilpon Hospital

    collaborator UNKNOWN
  • Policlinico G . Martino, Messina Italy

    collaborator UNKNOWN
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    collaborator OTHER
  • University Hospital of Ancona

    collaborator UNKNOWN
  • Buzzi Children's Hospital

    lead OTHER

Eligibility

Min Age
5 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2026-07-31
Completion
2026-10-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07126353 on ClinicalTrials.gov